Advisor OS LLC Acquires 762 Shares of The Clorox Company (NYSE:CLX)

Advisor OS LLC raised its holdings in The Clorox Company (NYSE:CLX) by 14.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,137 shares of the company’s stock after acquiring an additional 762 shares during the quarter. Advisor OS LLC’s holdings in Clorox were worth $997,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Catalyst Capital Advisors LLC bought a new position in shares of Clorox in the third quarter worth about $54,000. Los Angeles Capital Management LLC grew its stake in Clorox by 5.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock worth $31,266,000 after acquiring an additional 10,149 shares in the last quarter. Advisors Asset Management Inc. increased its position in shares of Clorox by 43.4% during the third quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock worth $4,865,000 after acquiring an additional 9,037 shares during the period. Natixis Advisors LLC increased its position in shares of Clorox by 8.3% during the third quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock worth $10,341,000 after acquiring an additional 4,839 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Clorox by 1.8% during the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock valued at $117,932,000 after acquiring an additional 13,038 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of CLX opened at $157.00 on Wednesday. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The stock has a fifty day moving average price of $157.40 and a 200-day moving average price of $160.13. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The firm has a market cap of $19.34 billion, a PE ratio of 42.90, a P/E/G ratio of 2.62 and a beta of 0.42.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the firm earned $2.16 earnings per share. Equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.11%. Clorox’s payout ratio is 133.33%.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. JPMorgan Chase & Co. raised their price objective on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Barclays raised their price target on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. DA Davidson decreased their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, February 5th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and boosted their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.